LH insider filings

LABCORP HOLDINGS INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen LH transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 10 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Caveney Brian J — EVP, Pres of BLS, CMO & CSO2—1 leg · 2,000 sh · $744,0801
Parham Richelle P — Director1—1 leg · 1,078 sh · $389,395—
Summy Amy B. — EVP, Chief Marketing Officer1—1 leg · 365 sh · $135,992—
Vaughn Bryan T — EVP and President, Diagnostics3—1 leg · 306 sh · $108,2324
Oyegunwa Akinbolade — EVP, CIO & CTO2——4
Meltzer Jonathan C — EVP, COO1——1

Recent insider filings — LABCORP HOLDINGS INC.

FiledFormInsiderReported transactionsSource
2026-11-184Summy Amy B. — EVP, Chief Marketing OfficerSale (S): 365 @ $372.58EDGAR
2026-11-124Caveney Brian J — EVP, Pres of BLS, CMO & CSOSale (S): 2,000 @ $372.04EDGAR
2026-11-054Vaughn Bryan T — EVP and President, DiagnosticsSale (S): 306 @ $353.70EDGAR
2026-11-034Parham Richelle P — DirectorSale (S): 1,078 @ $361.22EDGAR
2026-11-034Oyegunwa Akinbolade — EVP, CIO & CTOOption exercise (M): 370 · Tax withholding (F): 118 @ $355.59 · Option exercise (M): 370 (derivative) @ $0EDGAR
2026-11-034Vaughn Bryan T — EVP and President, DiagnosticsOption exercise (M): 500 · Tax withholding (F): 194 @ $355.59 · Option exercise (M): 500 (derivative) @ $0EDGAR
2026-09-034Vaughn Bryan T — EVP and President, DiagnosticsGrant/award (A): 1,500 (derivative) @ $0EDGAR
2026-09-034Meltzer Jonathan C — EVP, COOGrant/award (A): 900 (derivative) @ $0EDGAR
2026-09-034Oyegunwa Akinbolade — EVP, CIO & CTOGrant/award (A): 750 (derivative) @ $0EDGAR
2026-09-034Caveney Brian J — EVP, Pres of BLS, CMO & CSOGrant/award (A): 3,000 (derivative) @ $0EDGAR
2026-08-184ANDERSON KERRII B — DirectorSale (S): 3,000 @ $318.02EDGAR
2026-08-124Schechter Adam H — President & CEO, DirectorSale (S): 4,669 @ $320.37EDGAR
2026-08-064Summy Amy B. — EVP, Chief Marketing OfficerSale (S): 924 @ $306.74EDGAR
2026-08-054Wilkinson Peter J — SVP, Chief Accounting OfficerSale (S): 82 @ $309.22 · Option exercise (M): 1,338 @ $209.25 · Sale (S): 1,338 @ $309.23 · Option exercise (M): 1,338 (derivative) @ $0EDGAR
2026-07-064Vaughn Bryan T — EVP and President, DiagnosticsOption exercise (M): 327 · Tax withholding (F): 93 @ $283.88 · Sale (S): 234 @ $286.19 · Option exercise (M): 327 (derivative) @ $0EDGAR
2026-07-064Kyle Kathryn W — EVP, Chief Legal OfficerOption exercise (M): 256 · Tax withholding (F): 73 @ $283.88 · Sale (S): 92 @ $286.19 · Option exercise (M): 256 (derivative) @ $0EDGAR
2026-06-104Kyle Kathryn W — EVP, Chief Legal OfficerSale (S): 762 @ $263.89EDGAR
2026-05-134Schechter Adam H — President & CEO, DirectorSale (S): 5,903 @ $254.50EDGAR
2026-03-304Vaughn Bryan T — EVP, DiagnosticsGrant/award (A): 1,584 @ $0 · Tax withholding (F): 451 @ $268.38EDGAR
2026-03-304Meltzer Jonathan C — EVP, OperationsGrant/award (A): 2,388 @ $0 · Tax withholding (F): 711 @ $268.38 · Sale (S): 839 @ $267.05EDGAR
2026-03-304Kyle Kathryn W — EVP, Chief Legal OfficerGrant/award (A): 1,584 @ $0 · Tax withholding (F): 451 @ $268.38EDGAR
2026-03-304Oyegunwa Akinbolade — EVP, CIO & CTOGrant/award (A): 1,340 @ $0 · Tax withholding (F): 382 @ $268.38EDGAR
2026-03-304Bailey Megan D. — EVP, Pres, Central Labs & IntlGrant/award (A): 1,184 @ $0 · Tax withholding (F): 481 @ $268.38EDGAR
2026-03-304Summy Amy B. — EVP, Chief Marketing OfficerGrant/award (A): 3,994 @ $0 · Tax withholding (F): 1,836 @ $268.38EDGAR
2026-03-304Schroeder Mark S — EVP, Pres Diagnostics & COOGrant/award (A): 9,304 @ $0 · Tax withholding (F): 4,600 @ $268.38 · Grant/award (A): 2,968 @ $0 · Tax withholding (F): 1,468 @ $268.38EDGAR
2026-03-304Caveney Brian J — EVP, Pres of ED, CMO & CSOGrant/award (A): 9,304 @ $0 · Tax withholding (F): 4,042 @ $268.38 · Grant/award (A): 1,986 @ $0 · Tax withholding (F): 863 @ $268.38EDGAR
2026-03-304van der Vaart Sandra D — EVP, Corporate AffairsGrant/award (A): 6,382 @ $0 · Tax withholding (F): 2,722 @ $268.38EDGAR
2026-03-304Wilkinson Peter J — SVP, Chief Accounting OfficerGrant/award (A): 2,388 @ $0 · Tax withholding (F): 755 @ $268.38 · Sale (S): 1,633 @ $267.05EDGAR
2026-03-304Schechter Adam H — President & CEO, DirectorGrant/award (A): 58,470 @ $0 · Tax withholding (F): 26,106 @ $268.38EDGAR
2026-03-304GRAHAM ANITA Z — EVP, CHROGrant/award (A): 6,604 @ $0 · Tax withholding (F): 2,879 @ $268.38EDGAR
2026-03-054Schechter Adam H — President & CEO, DirectorSale (S): 8,705 @ $279.96EDGAR
2026-03-034van der Vaart Sandra D — EVP, Corporate AffairsSale (S): 547.54 @ $284.91EDGAR
2026-02-264Caveney Brian J — EVP, Pres of ED, CMO & CSOSale (S): 1,500 @ $286.31EDGAR
2026-02-234Wilkinson Peter J — SVP, Chief Accounting OfficerSale (S): 666 @ $277.94EDGAR
2026-02-134Kliphouse Kirsten Marie — DirectorOption exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0EDGAR
2026-02-134Wang Julia Aijun — Chief Financial Officer, EVPOption exercise (M): 860 · Tax withholding (F): 245 @ $289.89 · Option exercise (M): 860 (derivative) @ $0EDGAR
2026-02-134Summy Amy B. — EVP, Chief Marketing OfficerOption exercise (M): 230 · Tax withholding (F): 83 @ $289.89 · Option exercise (M): 230 (derivative) @ $0EDGAR
2026-02-134Schroeder Mark S — EVP, Pres Diagnostics & COOOption exercise (M): 806 · Tax withholding (F): 259 @ $289.89 · Option exercise (M): 806 (derivative) @ $0EDGAR
2026-02-134Wengel Kathryn E — DirectorOption exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0EDGAR
2026-02-134Caveney Brian J — EVP, Pres of ED, CMO & CSOOption exercise (M): 740 · Tax withholding (F): 211 @ $289.89 · Option exercise (M): 740 (derivative) @ $0EDGAR
2026-02-134Davis Jeffrey A. — DirectorOption exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0EDGAR
2026-02-134Rothman Paul — DirectorOption exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0EDGAR
2026-02-134Parham Richelle P — DirectorOption exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0EDGAR
2026-02-134van der Vaart Sandra D — EVP, Corporate AffairsOption exercise (M): 376 · Tax withholding (F): 99 @ $289.89 · Option exercise (M): 376 (derivative) @ $0EDGAR
2026-02-134Kong Garheng — DirectorOption exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0EDGAR
2026-02-134Wilkinson Peter J — SVP, Chief Accounting OfficerOption exercise (M): 536 · Tax withholding (F): 160 @ $289.89 · Option exercise (M): 160 · Tax withholding (F): 46 @ $289.89 · Option exercise (M): 536 (derivative) @ $0 · Option exercise (M): 160 (derivative) @ $0EDGAR
2026-02-134Schechter Adam H — President & CEO, DirectorSale (S): 5,273 @ $284.38 · Option exercise (M): 3,656 · Tax withholding (F): 1,521 @ $289.89 · Option exercise (M): 3,656 (derivative) @ $0EDGAR
2026-02-134NEUPERT PETER M — DirectorOption exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0EDGAR
2026-02-134ANDERSON KERRII B — DirectorOption exercise (M): 897 · Option exercise (M): 897 (derivative) @ $0EDGAR
2026-02-134GRAHAM ANITA Z — EVP, CHROOption exercise (M): 356 · Tax withholding (F): 109 @ $289.89 · Option exercise (M): 356 (derivative) @ $0EDGAR

Recent 8-K events — LABCORP HOLDINGS INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-218-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-308-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-228-K7.01 — Regulation FD DisclosureEDGAR
2026-09-108-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-288-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-178-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-148-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-07-308-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=LH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs